Global Gastroenteritis Testing Market Forecast 2026–2035: Long-Term Growth Insights
Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What size range is anticipated for the Gastroenteritis Testing Market from 2026 to 2030?
The gastroenteritis testing market has experienced robust growth in recent years. This market is projected to expand from $4.18 billion in 2025 to $4.44 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.1%. The growth observed in the historic period can be attributed to several factors, including the reliance on conventional immunoassay and culture-based methods, limited availability of advanced molecular diagnostics, an increasing prevalence of gastrointestinal infections, rising hospital and clinic diagnostic capabilities, and the expansion of research institutes focused on infectious disease studies.
The market for gastroenteritis testing is projected to experience robust expansion over the coming years. This market is anticipated to reach $5.55 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.8%. The expected growth during this forecast period is primarily driven by progress in molecular diagnostic technologies, an increasing need for quick point-of-care testing, enhanced financial support for infectious disease research, greater uptake of integrated laboratory information systems, and the broadening reach of gastroenteritis testing into developing markets. Key trends anticipated for the forecast period encompass a heightened demand for swift and precise gastroenteritis diagnostics, a growing preference for molecular diagnostic testing approaches, the broadening of testing panels to include viral, bacterial, and parasitic agents, an increase in point-of-care and hospital-based diagnostic solutions, and a stronger emphasis on epidemiological surveillance and the management of outbreaks.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20556&type=smp
What Drivers Are Affecting Demand In The Gastroenteritis Testing Market?
The escalating occurrence of bacterial infections is anticipated to stimulate the expansion of the gastroenteritis testing market moving forward. Bacterial infections are experiencing a surge due to heightened antibiotic resistance, increased population density, and more extensive global travel, all of which contribute to the dissemination of resistant bacteria. Gastroenteritis testing is essential for bacterial infections to accurately pinpoint the specific pathogen causing symptoms such as diarrhea and vomiting, thereby guiding appropriate treatment and preventing the spread of infection. For instance, in 2024, as per GOV.UK, a UK-based organization, serious cases of bacteraemia resulting from antibiotic-resistant bacteria have risen by 9.3% since 2023, climbing from 18,740 cases in 2023 to 20,484 cases in 2024. Therefore, the increasing incidence of bacterial infections is propelling the growth of the gastroenteritis testing market.
Which Segments Are Gaining Traction In The Gastroenteritis Testing Market?
The gastroenteritis testing market covered in this report is segmented –
1) By Type: Viral Gastrointestinal Infections, Bacterial Gastrointestinal Infections, Parasitic Gastrointestinal Infections
2) By Disease Strains: Bacterial Strains, Viral Strains, Parasitic Strains
3) By Testing Methods: Immunoassay Testing, Conventional Testing, Molecular Diagnostic Testing
4) By End-User: Hospitals, Clinics Or Medical Centers, Research Institutes, Diagnostic Laboratories
Subsegments:
1) By Viral Gastrointestinal Infections: Norovirus, Rotavirus, Astrovirus, Adenovirus, Sapovirus
2) By Bacterial Gastrointestinal Infections: Escherichia coli (E. coli), Salmonella, Campylobacter, Shigella, Clostridium perfringens
3) By Parasitic Gastrointestinal Infections: Giardia lamblia, Entamoeba histolytica, Cryptosporidium, Trichinella, Strongyloides stercoralis
How Are Emerging Trends Affecting The Progression Of The Gastroenteritis Testing Market?
Major companies in the gastroenteritis testing market are developing innovative products, such as molecular gastrointestinal tests, to provide high sensitivity and specificity. A molecular gastrointestinal test is a diagnostic approach that employs molecular techniques, like polymerase chain reaction (PCR), to detect and identify specific genetic material from pathogens or organisms in gastrointestinal samples. For instance, in June 2024, QIAGEN N.V., a Germany-based provider of sample and assay technologies, launched the QIAstat-Dx Gastrointestinal Panel 2. This panel is notable for its ability to rapidly and comprehensively detect up to 16 clinically relevant bacterial, viral, and parasitic pathogens responsible for most gastrointestinal infections. It utilizes real-time polymerase chain reaction (PCR) technology to amplify multiple genetic targets in a single reaction, which represents a significant improvement over traditional microbiological methods that typically require 24 hours to 10 days for sample incubation.
Who Are The Major Companies Operating In The Gastroenteritis Testing Market?
Major companies operating in the gastroenteritis testing market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Abbott Diagnostics, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Eurofins Scientific SE, Hologic Inc., Becton Dickinson and Company, bioMérieux SA, Quest Diagnostics Incorporated, DiaSorin S.p.A., Bio-Rad Laboratories Inc., Randox Laboratories Ltd., ARUP Laboratories, Meridian Bioscience Inc., MedGenome, Trinity Biotech plc, Savyon Diagnostics Ltd., Coris BioConcept, Aster Clinical Research & Diagnostic Centre Pvt. Ltd., Alimetrix Inc., Luminex Corporation
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/gastroenteritis-testing-global-market-report
Which Region Is Anticipated To See The Fastest Growth In The Gastroenteritis Testing Market?
North America was the largest region in the gastroenteritis testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroenteritis testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Gastroenteritis Testing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20556&type=smp
Browse Through More Reports Similar to the Global Gastroenteritis Testing Market 2026, By The Business Research Company
Gastroesophageal Reflux Disease Gerd Global Market Report 2026
Immunochemistry Diagnostic Devices And Equipment Global Market Report 2026
Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
